Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2008 1
2012 2
2013 1
2015 2
2016 3
2017 4
2018 4
2019 3
2020 4
2021 8
2022 13
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867. N Engl J Med. 2022. PMID: 35921451 Clinical Trial.
Capillary leak syndrome: State of the art in 2021.
Bichon A, Bourenne J, Gainnier M, Carvelli J. Bichon A, et al. Rev Med Interne. 2021 Nov;42(11):789-796. doi: 10.1016/j.revmed.2021.05.012. Epub 2021 Jun 4. Rev Med Interne. 2021. PMID: 34099313
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.
Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, Svoboda H, Britschgi M, Ostrowitzki S, Simuni T, Marek K, Koller M, Sevigny J, Doody R, Fontoura P, Umbricht D, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Front Neurol. 2021 Oct 1;12:705407. doi: 10.3389/fneur.2021.705407. eCollection 2021. Front Neurol. 2021. PMID: 34659081 Free PMC article.
Case report: Ribavirin and vitamin A in a severe case of measles.
Bichon A, Aubry C, Benarous L, Drouet H, Zandotti C, Parola P, Lagier JC. Bichon A, et al. Medicine (Baltimore). 2017 Dec;96(50):e9154. doi: 10.1097/MD.0000000000009154. Medicine (Baltimore). 2017. PMID: 29390321 Free PMC article.
The Neuropsychiatric Fluctuations Scale for Parkinson's Disease: A Pilot Study.
Schmitt E, Krack P, Castrioto A, Klinger H, Bichon A, Lhommée E, Pelissier P, Fraix V, Thobois S, Moro E, Martinez-Martin P. Schmitt E, et al. Among authors: bichon a. Mov Disord Clin Pract. 2018 Mar 23;5(3):265-272. doi: 10.1002/mdc3.12607. eCollection 2018 May-Jun. Mov Disord Clin Pract. 2018. PMID: 30363450 Free PMC article.
A randomized controlled double-blind study of rotigotine on neuropsychiatric symptoms in de novo PD.
Castrioto A, Thobois S, Anheim M, Quesada JL, Lhommée E, Klinger H, Bichon A, Schmitt E, Durif F, Azulay JP, Houeto JL, Longato N, Philipps C, Pelissier P, Broussolle E, Moro E, Tranchant C, Fraix V, Krack P; Honeymoon study group. Castrioto A, et al. Among authors: bichon a. NPJ Parkinsons Dis. 2020 Dec 15;6(1):41. doi: 10.1038/s41531-020-00142-x. NPJ Parkinsons Dis. 2020. PMID: 33319786 Free PMC article.
46 results